Matches in Nanopublications for { ?s ?p "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP598175.RAS5yX2tYHJL5wryWvyNXaVdYcsE2YIYsobRGI3afO8x8130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598175.RAS5yX2tYHJL5wryWvyNXaVdYcsE2YIYsobRGI3afO8x8130_provenance.
- NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261715.RAW4IzU0IqxoezOYvFIf-38VxK7CZK3WdpOz8wjKPkMa4130_provenance.
- assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397416.RAk8qrfx4_GDkoMEWuWwqkQ6fTcdjnRoVEBK1bGEzNGj8130_provenance.
- NP261873.RAmHNmt2ELzmpR0z0SE2W7JRpQCFW_yRBCJ0bWOg1zxWY130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261873.RAmHNmt2ELzmpR0z0SE2W7JRpQCFW_yRBCJ0bWOg1zxWY130_provenance.
- NP314772.RAsERRE2fKa3KLxHEkg0q8POzB0BGapchoag20lSrsV2U130_assertion description "[Twenty-two lesions from 17 patients with IPMT, including 12 benign (IPMT Adenoma) and 10 malignant (IPMT Carcinoma In Situ [CIS] (n = 4) and Invasive IPMT (n = 6) lesions, were immunostained for Survivin, p53, Bcl-2 and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314772.RAsERRE2fKa3KLxHEkg0q8POzB0BGapchoag20lSrsV2U130_provenance.